89 related articles for article (PubMed ID: 2076653)
1. In vitro activity of cefixime: correlation index between MIC and disc diffusion test.
Focà A; Liberto MC; Berlinghieri MC; Matera G; Puccio R; Carbone M; Fera MT
Drugs Exp Clin Res; 1990; 16(4):175-9. PubMed ID: 2076653
[TBL] [Abstract][Full Text] [Related]
2. Comparative in vitro activity of cefixime, cefaclor and loracarbef against urinary pathogens.
Hamilton-Miller JM; Brumfitt W
Drugs Exp Clin Res; 1991; 17(10-11):517-9. PubMed ID: 1841042
[TBL] [Abstract][Full Text] [Related]
3. Cefixime: spectrum of antibacterial activity against 16,016 clinical isolates.
Barry AL; Jones RN
Pediatr Infect Dis J; 1987 Oct; 6(10):954-7. PubMed ID: 3696835
[TBL] [Abstract][Full Text] [Related]
4. Cefixime shows good effects on group A and group B beta-haemolytic streptococci.
Liberto MC; Carbone M; Fera MT; Berlinghieri MC; Puccio R; Focà A; De Luca M; Casini A
Drugs Exp Clin Res; 1991; 17(6):305-8. PubMed ID: 1769318
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of PPI-0903M (T91825), a novel cephalosporin: bactericidal activity, effects of modifying in vitro testing parameters and optimization of disc diffusion tests.
Jones RN; Fritsche TR; Ge Y; Kaniga K; Sader HS
J Antimicrob Chemother; 2005 Dec; 56(6):1047-52. PubMed ID: 16239290
[TBL] [Abstract][Full Text] [Related]
6. Ceftriaxone against gram-negative and gram-positive bacteria: bactericidal and post-antibiotic effect.
Ravizzola G; Bonfanti C; Savoldi E; Turano A
Chemioterapia; 1985 Jun; 4(3):204-8. PubMed ID: 3875430
[TBL] [Abstract][Full Text] [Related]
7. Antibacterial activity of six beta-lactams and six quinolones against urinary gram negative bacteria.
Galante D; Esposito S; Barba D
Boll Ist Sieroter Milan; 1986; 65(5):361-7. PubMed ID: 3828090
[TBL] [Abstract][Full Text] [Related]
8. Tigecycline in vitro activity against gram-negative and gram-positive pathogens collected in Italy.
Roveta S; Marchese A; Debbia EA
Chemotherapy; 2008; 54(1):43-9. PubMed ID: 18073470
[TBL] [Abstract][Full Text] [Related]
9. Parameters characterizing the in vitro activity of cefixime, a new oral broad spectrum cephalosporin, against respiratory and urinary pathogens.
Debbia EA; Marchese A; Pesce A; Saverino D; Schito GC
J Chemother; 1992 Jun; 4(3):131-44. PubMed ID: 1517806
[TBL] [Abstract][Full Text] [Related]
10. Cefdinir: in vitro activity study and effect of human serum.
García-Rodríguez JA; Trujillano-Martín I; García-Sánchez JE
Drugs Exp Clin Res; 1993; 19(2):51-8. PubMed ID: 8223142
[TBL] [Abstract][Full Text] [Related]
11. Antimicrobial activity of fluoroquinolones and other antibiotics on 1,116 clinical gram-positive and gram-negative isolates.
Mascellino MT; Farinelli S; Iegri F; Iona E; De Simone C
Drugs Exp Clin Res; 1998; 24(3):139-51. PubMed ID: 9825230
[TBL] [Abstract][Full Text] [Related]
12. Comparative activity of ceftizoxime and four other cephalosporins against gram negative bacteria and their sensitivity to beta-lactamases.
Esposito S; Galante D; Barba D; Pennucci C; Limauro D
Microbiologica; 1985 Apr; 8(2):197-204. PubMed ID: 3874342
[TBL] [Abstract][Full Text] [Related]
13. In vitro antibacterial activity of aminosterols against multidrug-resistant bacteria from patients with cystic fibrosis.
Alhanout K; Brunel JM; Raoult D; Rolain JM
J Antimicrob Chemother; 2009 Oct; 64(4):810-4. PubMed ID: 19666647
[TBL] [Abstract][Full Text] [Related]
14. Cefixime versus cefotaxime against gram-negative bacteria causing urinary tract infections.
Carcía-Rodriguez JA; García-Sanchez JE; García-Garcia MI; García-Sanchez E; Munõz-Bellido JL; Trujillano I
J Chemother; 1989 Jul; 1(4 Suppl):112-3. PubMed ID: 16312329
[No Abstract] [Full Text] [Related]
15. Comparative in vitro activity of norfloxacin and four other chemotherapeutics against urinary gram-negative isolates.
Esposito S; Galante D; Pennucci C; Barba D; Limauro D; Scioli C
Chemioterapia; 1984 Jun; 3(3):196-9. PubMed ID: 6241506
[TBL] [Abstract][Full Text] [Related]
16. [Alteration of bacteria induced by subinhibitory concentrations of cefixime: consequences on bactericidal activity of human polynuclear neutrophils].
Labro MT; el Benna J; Jemni A
Pathol Biol (Paris); 1992 May; 40(5):427-32. PubMed ID: 1495824
[TBL] [Abstract][Full Text] [Related]
17. Antimicrobial activity and spectrum of ceftibuten (7432-S, SCH 39720)--a review of United States and Canadian results.
Jones RN
Diagn Microbiol Infect Dis; 1991; 14(1):37-43. PubMed ID: 2013209
[TBL] [Abstract][Full Text] [Related]
18. In vitro susceptibility tests with cefoperazone compared with cefotaxime, cefoxitin, cefuroxime, cephaloridine and gentamicin.
Brenciaglia MI; Cipriani P; Ghezzi MC; Giordano A; Mancini C; Rivanera D; Filadoro F
Chemioterapia; 1984 Aug; 3(4):246-9. PubMed ID: 6099754
[TBL] [Abstract][Full Text] [Related]
19. In vitro evaluation of a new cefixime-clavulanic acid combination for gram-negative bacteria.
Rawat D; Hasan AS; Capoor MR; Sarma S; Nair D; Deb M; Pillai P; Aggarwal P
Southeast Asian J Trop Med Public Health; 2009 Jan; 40(1):131-9. PubMed ID: 19323045
[TBL] [Abstract][Full Text] [Related]
20. In vitro brodimoprim activity on bacterial strains.
Benoit-Lemercier C; Bergogne-Bérézin E; Joly-Guillou ML
J Chemother; 1993 Dec; 5(6):435-43. PubMed ID: 8195835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
